Skip to content
Research Article Open access CC BY 4.0

The Prospect of Treating Alzheimer Disease through Sleep

Jin Huang

Journal of Pharmaceutical Research International · pp. 49–53 · Published 11 Jan 2021

10.9734/jpri/2020/v32i4031032

Abstract

Alzheimer's disease is caused by the deposition of amyloid and Tau proteins. These two proteins are present in normal brain cells, but in Alzheimer's disease, they accumulate in large quantities, affecting how brain cells function normally. The result is that brain cells can't communicate properly, leading to memory loss. The current treatment for Alzheimer's disease is mostly controlled by drugs. The three main drugs are Donepezil, Rivastigmine, and Galantamine, Reminyl. However, it has limited side effects and usually manifests as gastrointestinal distress. One of the functions of sleep is to accelerate the removal of amyloid in the brain, which can effectively improve the accumulation of amyloid and Tau proteins.

AD amyloid & tau proteins sleep deprivation sleep disorders sleep-rhythm

Cited by 1

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

4

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.